Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M. Sperger, Joshua M. Lang, Shuang G. Zhao et al.|Journal of Clinical Oncology|2021Cited by 62
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M. Sperger, Joshua M. Lang, Liguo Wang et al.|Clinical Cancer Research|2023Cited by 56
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Christos E. Kyriakopoulos et al.|Journal of Clinical Investigation|2022Cited by 33
Exploring Spatial-Temporal Changes in <sup>18</sup>F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With EnzalutamideChristos E. Kyriakopoulos, Glenn Liu, Elisabeth I. Heath et al.|Journal of Clinical Oncology|2020Cited by 29
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew L. Bootsma, Shuang G. Zhao, Rana R. McKay et al.|Journal of Clinical Oncology|2022Cited by 28